Advances for achieving a pathological complete response for rectal cancer after neoadjuvant therapy
Neoadjuvant therapy has become the standard of care for locally advanced mid-low rectal cancer. Pathological complete response (pCR) can be achieved in 12%â38% of patients. Patients with pCR have the most favorable long-term outcomes. Intensifying neoadjuvant therapy and extending the interval betwe...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
KeAi Communications Co., Ltd.
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/a23294fba1b44d69b6d32fbfc166caec |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!